Growth-related knee pain is quietly undermining youth athletic development, yet the field has lacked good data on which modifiable factors actually drive injury risk — leaving coaches, parents, and clinicians largely guessing. A new cross-sectional survey of 600 parents of male Japanese basketball players aged 9–15 offers some of the clearest population-level signal yet on what separates injured from uninjured young athletes.
Across all six grade cohorts (4th through 9th grade, 100 players each), 20.6% of participants reported growth-related knee pain within the preceding 12 months. Univariate analysis flagged older age, greater body size, heavier weekly training volume, and high sport specialization as significant correlates — while BMI, leg dominance, playing position, and court surface showed no meaningful association. In multivariate logistic regression, increased height emerged as an independent predictor with an odds ratio of 1.04 per centimeter, and sport specialization and training volume retained independent significance. The parent-reported methodology, while scalable, introduces recall and attribution bias, particularly in distinguishing true growth-related pathology (e.g., Osgood-Schlatter or Sinding-Larsen-Johansson disease) from contusions or sprains.
These findings align with the broader pediatric sports medicine literature linking rapid longitudinal bone growth to apophyseal stress at the tibial tubercle, a mechanism largely absent in adult overuse pathology. The sport specialization finding is particularly noteworthy: a growing body of evidence associates early single-sport focus with elevated injury rates, reduced athletic longevity, and burnout — and this study adds knee pathology in a growth-phase cohort to that ledger. The key practical implication at a population level is that training load management and delayed specialization may be the most tractable levers for reducing this injury pattern. As an observational, single-sex, single-sport study conducted in one cultural context, replication across diverse populations remains essential before broad clinical guidelines can be updated.
